Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JNGHF)

Every official Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR documents

• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-K 2026JNGHF 10-K 2026: annual report for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-K 2025JNGHF 10-K 2025: annual report for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-K 2024JNGHF 10-K 2024: annual report for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-K 2023JNGHF 10-K 2023: annual report for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-K 2022JNGHF 10-K 2022: annual report for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-Q 2026JNGHF 10-Q 2026: quarterly report for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-Q 2025JNGHF 10-Q 2025: quarterly report for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-Q 2024JNGHF 10-Q 2024: quarterly report for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-Q 2023JNGHF 10-Q 2023: quarterly report for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 10-Q 2022JNGHF 10-Q 2022: quarterly report for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 8-K 2026JNGHF 8-K 2026: current report for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 8-K 2025JNGHF 8-K 2025: current report for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 8-K 2024JNGHF 8-K 2024: current report for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 8-K 2023JNGHF 8-K 2023: current report for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 8-K 2022JNGHF 8-K 2022: current report for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR DEF 14A 2026JNGHF DEF 14A 2026: proxy statement for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR DEF 14A 2025JNGHF DEF 14A 2025: proxy statement for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR DEF 14A 2024JNGHF DEF 14A 2024: proxy statement for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR DEF 14A 2023JNGHF DEF 14A 2023: proxy statement for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR DEF 14A 2022JNGHF DEF 14A 2022: proxy statement for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR Form 4 2026JNGHF Form 4 2026: insider trading filing for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR Form 4 2025JNGHF Form 4 2025: insider trading filing for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR Form 4 2024JNGHF Form 4 2024: insider trading filing for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR Form 4 2023JNGHF Form 4 2023: insider trading filing for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR Form 4 2022JNGHF Form 4 2022: insider trading filing for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR S-1 2026JNGHF S-1 2026: registration statement for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR S-1 2025JNGHF S-1 2025: registration statement for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR S-1 2024JNGHF S-1 2024: registration statement for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR S-1 2023JNGHF S-1 2023: registration statement for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR S-1 2022JNGHF S-1 2022: registration statement for fiscal 2022
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 13F 2026JNGHF 13F 2026: institutional holdings for fiscal 2026
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 13F 2025JNGHF 13F 2025: institutional holdings for fiscal 2025
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 13F 2024JNGHF 13F 2024: institutional holdings for fiscal 2024
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 13F 2023JNGHF 13F 2023: institutional holdings for fiscal 2023
• Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR 13F 2022JNGHF 13F 2022: institutional holdings for fiscal 2022

More companies